Omada Health announces CEO transition; shares jump 21%

What happened

Omada Health, Inc. (NASDAQ: OMDA), a digital health services provider, filed a Current Report on Form 8-K with the SEC on August 6, 2026, disclosing two events: the release of its financial results for the quarter ended June 30, 2026, and a planned leadership transition. On the same day, the stock closed at $23.67, up 21.1% from the prior close of $19.54, with volume of 4.9 million shares – about four times the average daily volume.

The filing does not include the text of the earnings press release, so specific financial results are not available from this document. The leadership transition is described in detail.

Leadership transition

The company announced that Sean Duffy, its current Chief Executive Officer, will become Executive Chairman of the Board of Directors, effective January 1, 2027. Wei-Li Shao, the current President, will succeed Mr. Duffy as CEO on the same date. Both will continue in their present roles until the transition date. The Board approved the changes on August 5, 2026.

In connection with the transition, the Board also appointed Mr. Shao as a Class I director, effective on the transition date, with a term expiring at the 2029 Annual Meeting. Additionally, Jeryl Hilleman, currently Chairperson of the Board, was appointed Lead Independent Director, also effective on January 1, 2027. The Board has not yet approved compensation changes related to the transition.

Earnings release

Item 2.02 of the 8-K states that the company issued a press release announcing its financial results for the three months ended June 30, 2026. That press release was furnished as Exhibit 99.1 to the filing, but its contents are not reproduced in the excerpt provided. Accordingly, this article cannot report the specific revenue, profit, or guidance figures from the earnings announcement.

What this means

A Form 8-K is used by public companies to notify shareholders of material events that are not part of regular quarterly reports. Item 2.02 is used to disclose results of operations – companies often furnish (rather than file) earnings releases to avoid liability under securities laws for forward-looking statements. Item 5.02 requires disclosure of changes in directors or principal officers.

A CEO succession plan that gives the incumbent an executive chairman role is a structured leadership handover. It allows the outgoing CEO to remain involved while the incoming CEO takes operational control. The stock price surge on heavy volume may reflect investor optimism about the transition or the (undisclosed) earnings results, but the filing alone does not explain the cause of the price move.

Omada Health provides digital programs for chronic disease management, such as diabetes and hypertension. The company went public via a SPAC merger in 2021 and is classified as an emerging growth company, as noted in the filing.